Vanguard Investments Australia
IRMD icon

Vanguard Investments Australia’s iRadimed IRMD Stock Holding History

Vanguard Investments Australia’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Hold
2,113
– – ﹤0.01% 2104
2026
Q1 		$203K Buy
+2,113
New +$211K ﹤0.01% 2026

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Investments Australia's IRMD Position: Q2 2026 in Review

Vanguard Investments Australia held its iRadimed (IRMD) position steady in Q2 2026 at 2,113 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

Vanguard Investments Australia first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $203K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Vanguard Investments Australia held 2,113 shares of iRadimed worth $202K as of Q2 2026.
  • Vanguard Investments Australia left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2104 holding.
  • Vanguard Investments Australia first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's iRadimed position peaked at $203K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.